R e d u c e d s u b s i s t e n c e a l l o w a n c e

T.C.R. No. of Quota/ Export Authorization/ Permit Holder

The raw retention times t r(nc + 1) are plotted as a function of t r(nc), and the intercept a and slope b of the regression equation:

Article 2(c), (d), (g), (h), (i), (j), (k), (1), (p), (r), (s), (t), (u), (v) and (w)

Electrical Protection Act, R.S.N.W.T 1988, C.E-3 Department of Public Works and Services

in which, t R = retention time of the test substance, and t o = average time a solvent molecule needs to pass through the column (dead-time).

(taux minimal demandé par le demandeur de certificat) EUR/t net ŕ la date effective de la demande

Without prejudice to Article 5, for each Member State the reference level in tonnage at any given date after 1 January 2003 (R(GT)t) shall be equal to the reference level for that Member State set out in Annex I at 1 January 2003 (R(GT)03) adjusted by:

Muta. Cat. 3; R68 (Mutagenic category 3; Possible risk of irreversible effects) - T+; R28 (Very Toxic; Very toxic if swallowed) - T; R24 (Toxic; Toxic in contact with skin) - N; R 5 0-5 3 (Dangerous to the environment; Very Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment).

Without prejudice to Article 5, for each Member State the reference level in power at any given date after 1 January 2003 (R(kW)t) shall be equal to the reference level for that Member State set out in Annex I at 1 January 2003 (R(kW)03) as adjusted by deducting the total power of vessels leaving the fleet with public aid after 31 December 2002 (kWa).

E =p(r)tmM(r)T

L10F/I/M/R/V, I15A/V, K20I/M/R/T, L24I, I62V, G73S/T, V82A/F/S/T, I84V, L90M

In adaption (t), heading "R.

Hayes, R. C. Schnell and T. S. Miya.

[ 65 ml: ] After first opening use immediately within 24 h (stored 2 – 8 °C) or within 8 h (stored at r. t.)

Marcelin et al (2007) identified nine protease codons (L10F/I/M/R/V, I15A/V, K20I/M/R/T, L24I, I62V, G73S/T, V82A/F/S/T, I84V, L90M) that were associated with decreased virological response to saquinavir/ritonavir (1000/100 mg twice daily) in 138 saquinavir naive patients.

MacGregor, J. T., Schlegel, R., Choy, W.

Peeler, J.T., Horwitz, W. and Albert, R.

L10F/ I/ R/ V, K20M/ R, L24I, M46I/ L, F53L, I54L/ T/ V, L63P, A71I/ L/ T/ V, V82A/ F/ T, I84V and L90M.

Defined as HCV-RNA below limit of detection using a research based R T-PCR assay at end of treatment and during follow-up period

If RX differs by more than two standard deviations from the average R T value obtained for the control wine, adulteration may be assumed.

DT,R is the absorbed dose averaged over tissue or organ T, due to radiation R,

@ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ ] ^ _

Hayashi, M., Tice, R. R., MacGregor, J. T., Anderson, D., Blackey, D. H., Kirsch-Volders, M., Oleson, Jr.

ed ris tho r au ANNEX Ige lon SUMMARY OF PRODUCT CHARACTERISTICS t no uc rod lP nai dic Me

17 ed ris tho r au ge ANNEX III lon LABELLING AND PACKAGE LEAFLET t no uc rod lP nai dic Me

10V, 13V, 20M/ R/ V, 33F, 35G, 36I, 43T, 46L, 47V, 54A/ M/ V, 58E, 69K, 74P, 82L/ T, 83D and 84V.

L10V/ F/ R, I13V, K20R/ T, L33F/ V, M36I, M46I/ L, I47V/ L Q58E, I62V, L63P, V77I, I85V, and I93L.

the absorbed dose, in tissue or organ T weighted for the type and quality of radiation R. It is given by:

MacGregor, J. T., Wehr, C. M., Henika, P. R. and Shelby, M. E. (1990), The in vivo Erythrocyte Micronucleus Test:

Article 162(2) (a), (b), (c), (d), (e), (l), (q), (r), (s), (t) and (u) in cases of non-compliance by a contractor or a sponsor;

10V, 13V, 20M/ R/ V, 33F, 35G, 36I, 43T, 46L, 47V, 54A/ M/ V, 58E, 69K, 74P, 82L/ T, 83D and 84V) was applied to baseline viral protease sequences.

MacGregor, J. T., Heddle, J. A. Hite, M., Margolin, G. H., Ramel, C., Salamone, M. F., Tice, R. R., and Wild, D. (1987), Guidelines for the Conduct of Micronucleus Assays in Mammalian Bone Marrow Erythrocytes, Mutation Res., 189, pp. 103-112.

The density r in kilograms per metre cubed (kg/m3) of an ethanol-water mixture at temperature t in degrees Celsius is given by the formula below as a function of:

Tice, R. R., Hayashi, M., MacGregaro, J. T., Anderson, D., Blakey, D. H., Holden, H. E., Kirsch-Volders, M., Oleson Jr., F. B., Pacchierotti, F., Preston, R. J., Romagna, F., Shimada, H., Sutou, S. and Vannier, B. (1994), Report from the Working Group on the in Vivo Mammalian Bone Marrow Chromosomal Aberration Test, Mutation Res., 312, pp. 305-312.

Find the alcoholic strength at 20 °C using Table I. In the horizontal line of this table corresponding to the temperature T (expressed as a whole number) immediately below t °C, find the smallest density greater than rt. Use the tabular difference just below this density to calculate the density r at this temperature T.

Botham, P.A., Hall, T.J., Dennett, R., McCall, J.C., Basketter, D.A., Whittle, E., Cheeseman, M., Esdaile, D.J. & Gardner, J. (1992), The skin corrosivity test in vitro:

Whereas CEPT Recommendation T/R 25-07 on the coordination of frequencies for the European Radio Messaging System has designated the European channels for the ERMES system;

Member States shall, in accordance with CEPT Recommendation T/R 25-07 designate in the 169,4 to 169,8 MHz waveband four channels which shall have priority and be protected, and preferably be:

* Includes patients who did not receive ENF and those who were previously treated with and continued ENF **Mutations in HIV protease at positions L10V, I13V, K20M/ R/ V, L33F, E35G, M36I, K43T, M46L, I47V, I54A/ M/ V, 58E, H69K, T74P, V82L/ T, N83D or I84V ENF Enfuvirtide; TPV/ r Tipranavir/ ritonavir

MacGregor, J. T., Wehr, C. M. and Langlois, R. G. (1983), A Simple Fluorescent Staining Procedure for Micronuclei and RNA in Erythrocytes Using Hoechst 33258 and Pyromin Y, Mutation Res., 120, pp. 269-275.

Member States shall, in accordance with CEPT Recommendation T/R 22-02 of the European Conference of Postal and Telecommunications Administration designate the frequency band 1880-1900 MHz for digital European cordless telecommunications (DECT) by 1 January 1992.

Potential leakage should be measured by radioactively labelled albumin or erythrocytes injected into the perfusion circuit, with appropriate measures for continuous monitoring of radioactivity leakage into the systemic circulation (Hoekstra HJ, Naujocks T, Schraffordt Koops H, Beekhuis H, van Groningen a Stuling R, ter Veen H, et. al..

Fathur Rohman AL-GHOZHI (alias (a) Al Ghozi, Fathur Rohman, (b) Al Ghozi, Fathur Rahman, (c) Al-Gozi, Fathur Rohman, (d) Al-Gozi, Fathur Rahman, (e) Alghozi, Fathur Rohman, (f) Alghozi, Fathur Rahman, (g) Al-Gozhi, Fathur Rohman, (h) Al-Gozhi, Fathur Rahman, (i) Randy Alih, (j) Randy Ali, (k) Alih Randy, (l) Randy Adam Alih, (m) Sammy Sali Jamil, (n) Sammy Salih Jamil, (o) Rony Azad, (p) Rony Azad Bin Ahad, (q) Rony Azad Bin Ahmad, (r) Rony Azad Bin Amad, (s) Edris Anwar Rodin, (t) Abu Saad, (u) Abu Sa'ad, (v) Freedom Fighter);

m = amount of aflatoxin B1 in ng represented by the B1 peak of the sample, calculated as follows m = P (sample) P (st1) + P (st2) × 2 r (st) P (sample) = peak area of aflatoxin B1 for the sample P (st1) = peak area of aflatoxin B1 resulting from the preceeding injection of reference standard (3.13.3) P (st2) = peak area of aflatoxin B1 resulting from the following injection of reference standard (3.13.3) r (st) = injected amount of aflatoxin B1 in the reference standard (3.13.3) in ng Vm = volume of the injected sample extract in ml Ve x t = final volume of sample extract in ml, allowing for any dilution that was made (5.3) M = mass of sample in g Vf = volume of filtrate transferred to Florisil cartridge (5.4.1.2) in ml Vc = volume of chloroform, used for the extraction of the sample in ml If the procedure is followed as in this protocol, the formula reduces to: